Swedish equities closed higher on Tuesday, with the OMX Stockholm 30 index advancing 0.83% as broad-based buying lifted the market.
Advancing stocks outnumbered declining issues by 488 to 249, while 70 shares ended unchanged. Gains were led by the health care, telecommunications and industrials sectors, which offset losses in select defensive names.
Among the top performers, AstraZeneca led with a 2.61% rise, closing at 1,609.00 SEK. Sandvik added 1.99% to 394.80 SEK, while Alfa Laval gained 1.59% to 575.00 SEK. On the downside, Saab AB fell 0.62% to 638.20 SEK, Svenska Cellulosa SCA B declined 0.22% to 112.00 SEK and Essity B slipped 0.18% to 280.70 SEK.
Commodities showed mixed performance, with crude oil futures declining as Brent and WTI contracts fell 3.43% and 3.36%, respectively. Brent crude for November delivery settled at $87.43 per barrel, while West Texas Intermediate for October delivery ended at $82.15. Gold futures for December delivery edged 0.13% higher to $4,703.71 per troy ounce.
The Swedish krona strengthened modestly against the euro and U.S. dollar, with EUR/SEK falling 0.14% to 11.05 and USD/SEK down 0.22% to 9.47. The U.S. Dollar Index futures rose 0.05% to 98.88.
